K Syrjänen Selected Research

K Syrjänen Research Topics

Disease

18	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2010 - 05/2000
14	Neoplasms (Cancer) 03/2010 - 02/2000
8	Uterine Cervical Dysplasia 02/2007 - 05/2000
6	Colorectal Neoplasms (Colorectal Cancer) 07/2009 - 01/2006
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2006 - 02/2000
6	Carcinoma (Carcinomatosis) 11/2001 - 02/2000
4	Papillomavirus Infections 02/2015 - 06/2003
4	Neoplasm Metastasis (Metastasis) 01/2008 - 03/2006
3	Rectal Neoplasms (Rectal Cancer) 01/2011 - 03/2009
3	Infections 01/2011 - 07/2000
3	Carcinogenesis 01/2008 - 01/2006
2	Disease Progression 01/2004 - 06/2003
2	Ovarian Epithelial Carcinoma 10/2001 - 06/2000
1	Hypoxia (Hypoxemia) 03/2010
1	Fatigue 07/2009
1	Aneuploidy (Aneuploid) 01/2009
1	Substance-Related Disorders (Drug Abuse) 01/2008
1	Microsatellite Instability 01/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2004
1	Esophageal Squamous Cell Carcinoma 11/2001
1	Endometriosis 10/2001
1	Residual Neoplasm 10/2001
1	Epstein-Barr Virus Infections 09/2000
1	Carcinoma in Situ 07/2000
1	Ovarian Neoplasms (Ovarian Cancer) 06/2000
1	Margins of Excision 02/2000
1	Esophageal Neoplasms (Esophageal Cancer) 02/2000

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 02/2015 - 02/2000
4	Proteins (Proteins, Gene)FDA Link 03/2010 - 06/2000
3	Acetic Acid (Vinegar)FDA LinkGeneric 09/2005 - 01/2001
2	Biomarkers (Surrogate Marker)IBA 06/2011 - 01/2011
2	Fluorouracil (Carac)FDA LinkGeneric 01/2008 - 01/2007
2	Oncogene Proteins (Oncogene Protein)IBA 02/2007 - 11/2006
2	Biological ProductsIBA 10/2006 - 10/2001
2	Lugol's solution (Lugol's iodine)IBA 09/2005 - 01/2005
2	Indicators and Reagents (Reagents)IBA 11/2001 - 01/2001
2	Transcription Factors (Transcription Factor)IBA 07/2000 - 06/2000
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	VaccinesIBA 12/2010
1	Group II Phospholipases A2IBA 07/2009
1	IsoenzymesIBA 03/2009
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2009
1	Carbonic Anhydrase IXIBA 03/2009
1	Thymidylate SynthaseIBA 01/2008
1	beta CateninIBA 01/2008
1	Cell Adhesion MoleculesIBA 01/2008
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2007
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2007
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2006
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2006
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2006
1	Nucleoside-Diphosphate KinaseIBA 10/2006
1	trioctyl phosphine oxide (TOPO)IBA 10/2006
1	NF-kappa B (NF-kB)IBA 08/2006
1	Hormones (Hormone)IBA 05/2006
1	Tissue Inhibitor of Metalloproteinase-2IBA 03/2006
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2006
1	Matrix Metalloproteinases (MMPs)IBA 03/2006
1	Cadherins (E-Cadherin)IBA 01/2006
1	Vascular Endothelial Growth Factor CIBA 01/2006
1	Cyclin DIBA 10/2004
1	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2004
1	AntibodiesIBA 11/2001
1	Keratins (Keratin)IBA 11/2001
1	Protein Isoforms (Isoforms)IBA 01/2001
1	Etoposide (VP 16)FDA LinkGeneric 01/2001
1	Cisplatin (Platino)FDA LinkGeneric 01/2001
1	IodineIBA 01/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2001
1	SolutionsIBA 01/2001
1	Epirubicin (Ellence)FDA LinkGeneric 01/2001
1	NucleotidesIBA 07/2000
1	Messenger RNA (mRNA)IBA 06/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2000
1	A-Form DNA (A-DNA)IBA 06/2000
1	Transcription Factor AP-2IBA 06/2000
1	HPV DNA ProbesIBA 02/2000

Therapy/Procedure

5	Aftercare (After-Treatment) 11/2006 - 10/2004
3	Chemoradiotherapy 01/2011 - 03/2009
2	Radiotherapy 01/2011 - 03/2010
2	Palliative Care (Palliative Therapy) 07/2009 - 01/2008
2	Contraception (Birth Control) 01/2008 - 01/2004
2	Highly Active Antiretroviral Therapy (HAART) 01/2004 - 06/2003
2	Neoadjuvant Therapy 11/2001 - 01/2001
2	Therapeutics 11/2001 - 10/2001
1	Hormonal Contraception 01/2008
1	Drug Therapy (Chemotherapy) 01/2007
1	Hysterectomy 01/2001